BCA
MYOK

Berman Capital Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Berman Capital Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-14
Closed -$1K – 1908
2020
Q3 		$1K Hold
14
– – ﹤0.01% 1568
2020
Q2 		$1K Hold
14
– – ﹤0.01% 1574
2020
Q1 		$0 Buy
+14
New +$897 ﹤0.01% 1770

Berman Capital Advisors's MYOK Position: Q4 2020 in Review

Berman Capital Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 14 shares — an estimated $1K sold.

Berman Capital Advisors first reported a position in MYOK in Q1 2020 and held it in 3 quarters. The position peaked at $1K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Berman Capital Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Berman Capital Advisors sold 14 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $1K.
  • Berman Capital Advisors first reported a position in MyoKardia, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • Berman Capital Advisors's MyoKardia, Inc. Common Stock position peaked at $1K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Berman Capital Advisors's 13F filing for Q4 2020, filed 11 Feb 2021.